Once built to fight cancer, CAR‑T therapy is now offering new hope for patients with severe autoimmune disease.

Former Sen. Ben Sasse is taking Revolution Medicines' daraxonrasib, which has shown promise as a treatment for pancreatic ...

Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said.

Pharmaceutical giant Pfizer has abandoned negotiations to have a breakthrough cancer drug listed on the Pharmaceutical ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, British Columbia, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – The FDA approved the first perioperative immunotherapy ...

A positive phase three trial result in a hard-to-treat cancer adds fresh momentum to one of AstraZeneca's most important ...

Solid tumors often contain regions with very low oxygen levels, especially in their inner core. While these hypoxic ...

Cancer researchers at the University of Tennessee Health Science Center have published three groundbreaking studies demonstrating how advanced artificial intelligence and population health analytics ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC., Jan. 28, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary – As the global oncology clinical trials market surges toward a projected $25 ...

Add Yahoo as a preferred source to see more of our stories on Google. Jorge Manchola, a retired Air Force staff sergeant, was diagnosed with stage 4 lung cancer in 2023. The cancer had spread to his ...

Discover how advanced radiation and targeted therapies are transforming nasopharyngeal cancer care in India. Expert insights ...